Puma Biotechnology (PBYI) has entered into an agreement for Pint Pharma to commercialize NERLYNX in Argentina, Brazil, Chile, Colombia, Mexico and the rest of Latin America. NERLYNX is not approved for commercialization outside the US. Pint Pharma will be responsible for seeking the requisite …
0 Comments